CI&T Joins Claude Partner Network to Scale Claude Across the World's Largest Enterprises, with 1,000+ Certified AI Engineers Jun 08, 2026 CI&T Joins Claude Partner Network to Scale Claude Across the World's Largest Enterprises, with 1,000+ Certified AI Engineers. Learn more
CI&T Releases 2025 ESG Report Focused on Social Impact, Clean Energy, and Innovation Mar 26, 2026 CI&T Releases 2025 ESG Report Focused on Social Impact, Clean Energy, and Innovation Learn more
CI&T and AWS: how the partnership transformed customer service with generative AI at Alelo Aug 31, 2026 CI&Ters chatting animatedly in the office, tablet in hand: collaboration and technology, part of everyday life at the company. Learn more
CI&T Recognized in Everest Group’s 2025 Global PEAK Matrix® Assessments for Retail and Consumer Packaged Goods Services Dec 10, 2025 CI&T Recognized in Everest Group’s 2025 Global PEAK Matrix® Assessments for Retail and Consumer Packaged Goods Services Learn more
Don't let FDA Submission Stall your Product An approach to applying agile principles in a regulated environment Download Agile methodologies have long fueled software innovation, but navigating compliance adds complexity in regulated industries like healthcare. CI&T’s solution? The Minimally Regulated Viable Product (MRVP) approach. The release-derisking MRVP approach accelerates medical product launches while ensuring regulatory compliance, reshaping agile in regulated environments. Access our content to learn how the MRVP framework ensures medical product viability amid regulatory challenges.